Objective: To develop a simple standardized clinical score to stratify emergency ward patients with clinically suspected pulmonary embolism (PE) into groups with a high, intermediate, or low probability of PE to improve and simplify the diagnostic approach.
A
LTHOUGH NEWLY available, noninvasive diagnostic tools (leg vein ultrasonography [1] [2] [3] [4] and plasma D-dimer measurement 2, [5] [6] [7] ) are being increasingly used in the workup of suspected pulmonary embolism (PE), clinical assessment of PE remains a cornerstone of the recently validated diagnostic strategies for PE. 2, 4, 8, 9 Indeed, the socalled clinical or pretest probability (which rests on risk factors for venous thromboembolism, history, physical examination, blood gases, chest x-ray examination, and electrocardiogram) may aid in both the selection and interpretation of further diagnostic tests. Moreover, patients with a low clinical probability of PE seldom require a pulmonary angiogram.
Although individual symptoms, signs, and findings on frequently performed tests (chest x-ray examination, electrocardiogram, and blood gases) are neither sensitive nor specific for PE, 10, 11 their combination, either empirical 2, 9, 12 or by a scoring system, 4, 8 allows a fairly accurate classification of patients suspected of having PE into 3 clinical probability categories, ie, low, intermediate, and high. For example, in a database combining 2 prospective management studies of PE diagnosis, 9 41% of the patients had a low clinical probability of PE, and the prevalence of PE was only 8%, a figure similar to that obtained in the PIOPED study. 12 None of these patients required a pulmonary angiogram. However, the predictive value of a high clinical probability of PE was poor (67% of patients with PE), and clinical probability was assessed empirically in these trials. In a recent Canadian trial, 4 probability of PE was assessed by a clinical model based on the presence of risk factors for venous thromboembolism and clinical signs and symptoms. Although safe and effective for reducing the need for invasive testing, this score was highly dependent on the clinician's decision of whether an alternative diagnosis was as or more likely than PE and was, therefore, explicit but not standardized. Finally, a score has also been developed by an Italian group, 8 but it rested on assessment by a limited number of highly spe-
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cialized pulmonary physicians and included sophisticated and potentially unreliable readings of chest x-ray films.
Therefore, we performed the present study to develop a simple standardized estimate of clinical probability of PE from a database of consecutive unselected patients admitted to the emergency ward for clinically suspected PE in whom the diagnosis of PE was established or excluded by a standardized algorithm.
RESULTS

CHARACTERISTICS OF STUDY POPULATIONS
A total of 1090 consecutive patients were evaluated. Their characteristics are displayed in Table 2 . The median age of the patients was 62 years (range, 17-97 years).
PREDICTOR VARIABLES OF PE
Except for sex, recent cough, stroke, cancer, chronic obstructive pulmonary disease, heart disease, estrogen treatment, and recent trauma, all variables were significantly associated with PE in univariate analysis (Table 2) . Patients with confirmed PE slightly differed in age and sex from those without PE (mean±SD age, 67.6 ± 16.7 years and 57.2 ± 18.8 years, respectively; 49% and 43.6% male, respectively). Among patients with PE, the mean ± SD PaO 2 was 8.8 ± 2.0 kPa compared with 10.3 ± 2.4 kPa in patients without PE (PϽ.001). The mean ± SD PaCO 2 was 4.5 ± 0.7 kPa in
PATIENTS AND METHODS
PATIENTS
The data analyzed herein were pooled from 2 previous studies, 2, 6 totaling 1093 consecutive patients more than 16 years old who presented with clinically suspected PE to the emergency center of the University Hospital of Geneva, Geneva, Switzerland, between October 1, 1992, and October 31, 1997. Exclusion criteria in these trials were as follows: suspected PE during hospital stay, symptoms of deep vein thrombosis (DVT), DVT or PE in the previous 3 months, refusal or inability to consent, contraindication or impossibility to perform pulmonary angiography, ongoing anticoagulant treatment at study entry, expected survival less than 3 months, impossible follow-up, or lung scan read in comparison to a previous examination. Three patients were excluded from the present analysis because they had a large number of missing items (PaO 2 , PaCO 2 , oxygen alveolararterial difference [PAO 2 −PaO 2 ], platelike atelectasis, pleural effusion, and/or elevation of a hemidiaphragm).
DIAGNOSTIC STUDIES
Diagnosis of PE rested on a sequence of noninvasive instruments, including clinical assessment, lung scan, enzyme-linked immunosorbent assay (ELISA) plasma D-dimer measurement, and lower limb venous compression ultrasonography. Throughout the 2 studies on which we performed the present analysis, no change occurred in the methods and availability of all diagnostic tests, except for D-dimer. Plasma D-dimer was assayed by the Asserachrom D-Di enzyme immunoassay kit (Diagnostica Stago, Asnières-sur-Seine, France) in the first study and by a rapid ELISA assay (Vidas DD; bioMérieux, Lyon, France) in the second study. 2 However, both assays were ELISAs, and they had a very similar performance. An angiogram was performed in patients with an inconclusive noninvasive workup. In the second study, 2 the diagnostic sequence was modified, plasma D-dimer and ultrasonography being performed before instead of after lung scan. Pulmonary embolism was ruled out by a normal lung scan, an ELISA plasma D-dimer level of less than 500 µg/L, the combination of low clinical probability and a nondiagnostic lung scan, or a normal angiogram. Pulmonary embolism was established by a high-probability lung scan, a DVT shown by ultrasonography, or an abnormal angiogram. The diagnosis of PE was established in 296 patients by a high-probability lung scan, a DVT shown by ultrasonography and an abnormal lung scan, a pulmonary angiogram showing an embolus, a high clinical probability and an abnormal albeit nondiagnostic lung scan, or a high clinical suspicion with echocardiographic signs of acute right ventricular pressure overload. These last 2 criteria were used in only 17 patients (1.6% of the entire population). Criteria for absence of PE were a normal or near-normal lung scan or a normal pulmonary angiogram. Moreover, a plasma D-dimer level below 500 µg/L or the combination of a low empirical clinical probability of PE and a low-probability lung scan were considered to rule out PE in the absence of venous thromboembolic events during 3-month follow-up. The prevalence of PE in this population (27%), as well as the proportion of normal and high-probability lung scans, is consistent with that in other series reported in the literature.
12,13
FOLLOW-UP
Venous thromboembolic events (DVT or PE) and episodes of bleeding were recorded during the 3-month followup. Patients were followed up by their family physicians and were interviewed by telephone by one of the study coordinators at the end of the follow-up period. The family physician was contacted whenever a possible event was disclosed by the interim history, and charts were reviewed if a patient was readmitted to a hospital for any cause. The death registries of Geneva and the Province of Quebec were consulted for patients who could not be traced after checking with the family physician. For patients who died, the cause of death was ascertained either by autopsy or the death certificate. Follow-up was completed in 99.3% of patients.
STUDY DESIGN
On study entry, patients were examined by a physician in the emergency ward who rated the probability of PE as low WWW.ARCHINTERNMED.COM 93 patients with PE and 4.8 ± 0.9 kPa in patients without PE (PϽ.001).
In multivariate analysis, 8 predictors showed a significant association with PE: recent surgery, previous thromboembolic event, older age, hypocapnia, hypoxemia, tachycardia, platelike atelectasis, or elevation of a hemidiaphragm on chest x-ray film ( Table 3) .
CLINICAL SCORE
Based on multivariate regression coefficients, a clinical risk score ranging from 0 to 16 points was established in 986 patients (104 patients had missing data, mainly arterial blood gas analysis not performed or performed while breathing oxygen) ( Table 3 ). The best cutoff score for identifying a low-probability group as large as possible while not exceeding a prevalence of PE of 12% was 4 points or less (Figure) . After the individual risk scores were calculated, patients with a total score of 4 or less were assigned to the low-probability category (486 patients [49%]; prevalence of PE, 10%), those with a total score of 5 to 8 points to the intermediate-probability category (437 patients [44%]; prevalence of PE, 38%), and those with a total score of 9 points or higher to the high-probability category (63 patients [6%]; prevalence of PE, 81%). The difference in prevalence of PE in the 3 categories was statistically significant. The prevalence of PE for each score is given in the Figure. 
CROSS VALIDATION
When the 8 variables in the prediction model were allowed to vary independently, the AUC was 0.79 (range, (0% to 20%), high (80% to 100%), or intermediate (21% to 79%) before any other test to avoid bias. Data were collected by means of a standardized case report form, including the variables listed in Table 1 . The list was established on the basis of the literature. 10, 11, 14 The variables fell into 4 groups: signs and symptoms of PE, risk factors for PE, interpretation of the chest radiograph, and measurement of arterial blood gas.
Patients were considered to have chronic heart disease (coronary heart disease, heart failure, or arrhythmia), chronic venous disease (varicose veins, chronic insufficiency), cancer, history of previous DVT or PE, stroke, or chronic obstructive pulmonary disease if these conditions were known before admission. Recent cough was defined as cough during the last 3 days. Recent major surgery was defined as orthopedic, hip, knee, or extensive pelvic or abdominal surgery during the last month. Only trauma of the inferior limbs, pelvis, or spine during the last month was considered. Bed rest of 48 hours or more and air or road travel of 6 hours or more during the last week were considered as recent immobilization. Postpartum period was defined as up to 4 weeks after delivery. Arterial blood samples were obtained while the patients were breathing room air. Oxygen alveolar-arterial difference (PAO 2 −PaO 2 ) was calculated from the following simplified equation: PAO 2 =PIO 2 − (PCO 2 /0.8)−PaO 2 . Chest radiographs were obtained at the time of study entry using a stationary x-ray unit. In most patients, anteroposterior chest radiographs were obtained in the semirecumbent position. Chest radiographs were examined by the physician of the emergency ward. Care was taken to identify band atelectasis, pleural effusion, and position of the diaphragm. Questionnaires were completed before the patients underwent specific diagnostic tests, and they were systematically reviewed for completeness.
ANALYSIS
Descriptive statistics were applied for all variables collected. The univariate relation between baseline characteristics and presence of PE was examined by the Fisher exact test for categorical variables. All candidate predictor variables associated with diagnosis of PE in univariate analysis were incorporated into a multivariate logistic regression model. For all analyses, a 2-tailed P value of less than .05 indicated statistical significance. Negative predictive value was the proportion of patients with a low probability score among those classified as not having PE.
CLINICAL SCORE FOR ASSESSING CLINICAL PROBABILITY OF PE
A simple integer diagnostic score was computed from the multivariate logistic regression model, assigning points in proportion to the regression coefficients. The ideal score was defined as a score based on objective and reproducible variables, clinically relevant for the diagnosis of PE. The individual diagnostic scores were calculated, and the patients were assigned to a low-, intermediate-, or highprobability category. The optimal cutoff for discriminating between the low-and intermediate-or high-probability categories was chosen to identify a low-probability group as large as possible with a prevalence of PE below 12%, a figure found in previous studies using empirical probability. 2, 9, 12 To examine the degree of overfitting of the prediction model to the development sample, we performed a crossvalidation procedure. 15 First, the sample was split at random into 10 equal groups. Second, a logistic regression model predicting diagnosis of PE was developed on nine tenths of the sample, and the resulting prediction equation was applied to the remaining tenth; this procedure was repeated 10 times, each time rotating the cross-validation subset. Finally, the ability of the cross-validated scores to predict PE was examined by comparing the area under the receiver operating characteristic curve (AUC) 16 with that obtained from the naive prediction scores, without cross validation. This cross-validation procedure was performed for the full multivariable prediction model, where each covariate was assigned a separate regression coefficient, and for the simple model, where the clinical probability score was the sole predictor. Confidence intervals on AUCs were obtained by the bootstrap method 17 : 250 subsamples with sample sizes of 986 were taken with replacement from the original sample, the AUC was computed in each, and the 95% confidence interval was derived from percentiles 2.5 and 97.5 of the distribution of AUCs. 
COMPARISON WITH EMPIRICAL PROBABILITY ASSESSMENT
In all patients, the clinical probability of PE was evaluated empirically by an emergency ward physician, usually a second-or third-year internal medicine resident. The accuracy of the empirical assessment is similar to that of the prediction by the score ( Table 4 ). The score tended to identify the patients with a high clinical probability more accurately than empirical evaluation (prevalence of PE: 81% vs 66%, respectively), but the difference did not reach statistical significance.
COMMENT
In this study, we identified the main characteristics associated with PE in a cohort of consecutive outpatients admitted to the emergency ward with clinically suspected acute PE and combined them into an easily calculated score (Table  3) to predict the probability of PE before specific tests for the disease, such as plasma D-dimer measurement, lower limb venous ultrasonography, lung scan, and pulmonary angiography. This score is based on clinical, arterial blood gas analysis, and chest x-ray findings, which are widely available in the emergency ward. It allows classifying patients into 3 categories of clinical probability of PE with a fair degree of accuracy. The prevalence of PE is only 10% in the low-probability category (which included 49% of the entire cohort), 38% in the intermediate-probability category (44% of all patients), and 81% in the high-probability category (6% of all patients). Hence, the accuracy of the prediction rule is comparable to that of empirical clinical probability assessment in our institution (Table 4 ). The advantage of the score over empirical or implicit evaluation by the clinician lies in its explicitness and, therefore, its standardization. Moreover, the score was developed in a cohort of unselected consecutive outpatients, because our hospital is both a primary and a tertiary hospital, and most of these patients were not referred. Therefore, we believe this score could also be applied to other institutions. The importance of clinical evaluation in suspected PE is highlighted by several recent studies. 2, 4, 8, 9, 12 The influence of clinical probability, also named prior or pretest probability, on the predictive value of any diagnostic test is well known and can be inferred from Bayes rule. 18 In the realm of PE diagnosis, the PIOPED study 12 applied this concept to lung scan and was able to prove its relevance by showing that the prevalence of angiographically proven PE was only 4% in patients with both a lowprobability lung scan and a low clinical probability of PE. Application of the score to the study population. Also indicated under the graph are the mean prevalence of pulmonary embolism (PE) and the proportion of patients in each clinical probability category (low clinical probability defined as a score of 0 through 4, intermediate as a score of 5 through 8, and high as a score of 9 or above). 
